跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
SELINCRO 18 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
SELINCRO 18 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
H. Lundbeck A/S
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 20, 2024
Approval ID
dd14b37704a2910b
Company
H. Lundbeck A/S
Type
Standard
Approval Details
Approval Id
dd14b37704a2910b
Drug Cima Aemps Name
SELINCRO 18 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
112815002IP
Holder Company Name
H. Lundbeck A/S
Marketing Company Name
Elam Pharma Labs S.L.
Holder Company Detail Path
/organization/h-lundbeck-a-s
Authorization Date
2024-11-20
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
18 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
H. Lundbeck A/S
Company Detail Path
/organization/h-lundbeck-a-s
Company Information
Pharmaceutical Company Name
H. Lundbeck A/S
Name En
H. Lundbeck A/S
Country Name
Denmark
City Name
valby,hovedstaden,country_dk
Address
Ottiliavej 9
Website
https://www.lundbeck.com
Active Ingredients
NALMEFENO
18 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 20, 2024
Approval ID
dd14b37704a2910b
Type
Standard
Back to CIMA-AEMPS Approvals
SELINCRO 18 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
